-transparent.png){kind=logo}
A series of 5,6,6a,8,9,11a-hexahydroanaphth[1',2':4,5]imidazo[2,q-b]thiazoles (17 and 20) and 5,6,6a,9,10,11a-hexahydronaphth[2',1':4,5]imidazo[2,1-b]thiazoles has been synthesized with cis- and/or trans-1,2-diamino-1,2,3,4-tetrahydronaphthalenes as the key intermediates and subsequently evaluated for immunological activity (effects on antibody formation and delayed-type hypersensitivity reaction). Among the compounds tested trans-5,6,6a,8,9,11a-hexahydronaphth[1',2':4,5]imidazo[2,1-b]thiazole (trans-17a) and (+/-)-5,6,6a beta,8,9,11a alpha-hexahydro-8 beta-hydroxy-9 beta-methyl-8 alpha-phenylnaphth[1',2':4,5]imidazo[2,1-b]thiazole (20a) showed the largest immunological activity in mice with a magnitude comparable to that of levamisole and were found to be considerably less toxic than levamisole in acute toxicological study. The structures of 18a and 20a were determined by X-ray crystallography.
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
September 2001,
European journal of medicinal chemistry,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
December 2006,
Journal of medicinal chemistry,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
January 1992,
Acta pharmaceutica Nordica,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
October 2013,
European journal of medicinal chemistry,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
November 1980,
Bollettino chimico farmaceutico,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
May 1988,
Il Farmaco; edizione scientifica,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
January 1994,
Journal de pharmacie de Belgique,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
April 2005,
Journal of medicinal chemistry,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
July 2012,
Carbohydrate research,
M Saito, and
Y Kayama, and
T Watanabe, and
H Fukushima, and
T Hara, and
K Koyano, and
A Takenaka, and
Y Sasada
October 2012,
Organic & biomolecular chemistry,
